Protein & Cell

, Volume 1, Issue 4, pp 342–354

Roles of the hemagglutinin of influenza A virus in viral entry and development of antiviral therapeutics and vaccines

Review

DOI: 10.1007/s13238-010-0054-6

Cite this article as:
Jiang, S., Li, R., Du, L. et al. Protein Cell (2010) 1: 342. doi:10.1007/s13238-010-0054-6

Abstract

Seasonal influenza epidemics and influenza pandemics caused by influenza A virus (IAV) has resulted in millions of deaths in the world. The development of anti-IAV vaccines and therapeutics is urgently needed for prevention and treatment of IAV infection and for controlling future influenza pandemics. Hemagglutinin (HA) of IAV plays a critical role in viral binding, fusion and entry, and contains the major neutralizing epitopes. Therefore, HA is an attractive target for developing anti-IAV drugs and vaccines. Here we have reviewed the recent progress in study of conformational changes of HA during viral fusion process and development of HA-based antiviral therapeutics and vaccines.

Keywords

influenza A virus hemagglutinin viral entry antiviral drugs vaccines 

Copyright information

© Higher Education Press and Springer-Verlag Berlin Heidelberg 2010

Authors and Affiliations

  1. 1.Lindsley F. Kimball Research InstituteNew York Blood CenterNew YorkUSA
  2. 2.School of Pharmaceutical SciencesSouthern Medical UniversityGuangzhouChina

Personalised recommendations